We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $5.13B
1-Year Est. Return 11.51%
This Fund
S&P 500
This Quarter Est. Return
+6.05%
1 Year Est. Return
+11.51%
3 Year Est. Return
+68.19%
5 Year Est. Return
+90.4%
10 Year Est. Return
+384.43%
AUM
$2.85B
AUM Growth
+$49.7M
Cap. Flow
-$75.2M
Cap. Flow %
-2.64%
Top 10 Hldgs %
41.46%
Holding
236
New
11
Increased
27
Reduced
106
Closed
12

Top Buys

Rank Stock Value
1
LUMN icon
Lumen
LUMN
+$11.8M
2
CACC icon
Credit Acceptance
CACC
+$5.56M
3
RDNT icon
RadNet
RDNT
+$4.84M
4
EPD icon
Enterprise Products Partners
EPD
+$3.54M
5
WAB icon
Wabtec
WAB
+$2.7M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$28.9M
2
QCOM icon
Qualcomm
QCOM
+$10M
3
DOV icon
Dover
DOV
+$6.22M
4
ABT icon
Abbott
ABT
+$3.3M
5
BX icon
Blackstone
BX
+$2.94M

Sector Composition

Rank Sector Weight
1 Financials 30.92%
2 Healthcare 16.7%
3 Technology 13.21%
4 Communication Services 10.46%
5 Industrials 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LSXMA
176
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$245K 0.01%
8,976
– –
EXG icon
177
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$2.93B
$242K 0.01%
29,250
– –
DFS
178
DELISTED
Discover Financial Services
DFS
$233K 0.01%
3,000
– –
TD icon
179
Toronto Dominion Bank
TD
$199B
$233K 0.01%
4,000
– –
LUMN icon
180
CALL
Lumen
LUMN
$7.04B
$232K 0.01%
+1,406
New +$15.8K
SCHW
181
Charles Schwab
SCHW
$186B
$232K 0.01%
5,768
+670
+13% +$29.2K
VB icon
182
Vanguard Morningstar Small-Cap ETF
VB
$78.5B
$232K 0.01%
1,480
– –
ACN icon
183
Accenture
ACN
$118B
$231K 0.01%
1,250
– –
L icon
184
Loews
L
$22.3B
$230K 0.01%
4,200
– –
AMT icon
185
American Tower
AMT
$82.8B
$227K 0.01%
1,109
+63
+6% +$12.7K
TEVA icon
186
CALL
Teva Pharmaceuticals
TEVA
$45.7B
$226K 0.01%
+2,235
New +$26.9K
VEU icon
187
Vanguard FTSE All-World ex-US ETF
VEU
$69.1B
$226K 0.01%
4,440
– –
META icon
188
Meta Platforms (Facebook)
META
$1.71T
$217K 0.01%
+1,125
New +$206K
EVV
189
Eaton Vance Limited Duration Income Fund
EVV
$1.01B
$213K 0.01%
16,800
– –
PARAA
190
DELISTED
Paramount Global Class A
PARAA
$210K 0.01%
+4,200
New +$208K
MDT icon
191
Medtronic
MDT
$120B
$209K 0.01%
+2,143
New +$196K
HCA icon
192
HCA Healthcare
HCA
$91.8B
$203K 0.01%
1,505
-3,550
-70% -$449K
MSI icon
193
Motorola Solutions
MSI
$77.6B
$200K 0.01%
1,200
-528
-31% -$79.5K
NOV icon
194
NOV
NOV
$7.48B
$200K 0.01%
9,000
-4,200
-32% -$101K
HPE icon
195
Hewlett Packard
HPE
$74.2B
$157K 0.01%
10,500
-1,500
-13% -$22.7K
QVCGA
196
DELISTED
QVC Group Inc Series A
QVCGA
$155K 0.01%
258
– –
GCVRZ
197
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$153K 0.01%
+294,529
New +$147K
TSQ icon
198
Townsquare Media
TSQ
$94.1M
$142K 0.01%
26,400
+1,200
+5% +$6.73K
QVCGB
199
DELISTED
QVC Group, Inc. Series B Common Stock
QVCGB
$129K ﹤0.01%
215
– –
HBP
200
DELISTED
Huttig Building Products, Inc.
HBP
$128K ﹤0.01%
49,688
+1,000
+2% +$2.65K
5 6 7
8
9

Similar funds

ACM
AKRE Capital Management Middleburg, Virginia $5.12B AUM 19.08% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5.14B AUM 6.88% 1-Year Est. Return
CFO
Callan Family Office Radnor, Pennsylvania $5.11B AUM 35.28% 1-Year Est. Return
SB
SIG Brokerage New York $5.15B AUM 78.53% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $5.1B AUM 214.22% 1-Year Est. Return
KACA
Kayne Anderson Capital Advisors Los Angeles, California $5.1B AUM 17.16% 1-Year Est. Return

Beck Mack & Oliver's Q2 2019 Portfolio in Review

As of Q2 2019, Beck Mack & Oliver held 236 positions worth $2.85B, up 1.8% from $2.8B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Beck Mack & Oliver's Q2 2019 filing shows 11 new, 27 increased, 106 reduced and 12 closed positions. Its largest new stake was Focus Financial Partners Inc. Class A: 31,150 shares worth $851K. The largest sale was Teva Pharmaceuticals, an estimated $28.9M.

By sector, the portfolio is most concentrated in Financials at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Technology.

  • Beck Mack & Oliver's largest Q2 2019 buy was Focus Financial Partners Inc. Class A: 31,150 shares worth $851K.
  • Beck Mack & Oliver added most to Lumen in Q2 2019, an estimated $11.8M increase.
  • Beck Mack & Oliver's biggest Q2 2019 reduction was Teva Pharmaceuticals, cutting an estimated $28.9M.
  • Beck Mack & Oliver fully exited Unilever NV New York Registry Shares in Q2 2019, selling an estimated $656K.
  • Beck Mack & Oliver's ten largest holdings make up 41% of its $2.85B portfolio in Q2 2019.
  • Beck Mack & Oliver opened 11 new positions and closed 12 in Q2 2019.
  • Beck Mack & Oliver's portfolio value rose 1.8% quarter-over-quarter to $2.85B.

Based on Beck Mack & Oliver's 13F filing for Q2 2019, filed 13 Aug 2019.